hyperbilirubinemia
Chronic treatment at 400 mg BID was not feasible due to reversible, cholestatic liver dysfunction [NCI-CTC Grade 3 conjugated hyperbilirubinemia (n=2), Grade 3 elevated gamma-glutamyl transpeptidase (GGT) (n=1)].